Jacobio Pharmaceuticals Group Co., Ltd. (OTCMKTS:JBPHF) Short Interest Down 60.5% in November

Jacobio Pharmaceuticals Group Co., Ltd. (OTCMKTS:JBPHF) was the target of a significant decrease in short interest in November. As of November 15th, there was short interest totalling 303,900 shares, a decrease of 60.5% from the October 31st total of 768,900 shares. Based on an average daily volume of 0 shares, the short-interest ratio is presently ∞ days.

Jacobio Pharmaceuticals Group Stock Performance

Shares of OTCMKTS:JBPHF opened at $0.30 on Friday. Jacobio Pharmaceuticals Group has a 52-week low of $0.30 and a 52-week high of $0.30. The business has a fifty day moving average of $0.30 and a two-hundred day moving average of $0.30.

About Jacobio Pharmaceuticals Group

Jacobio Pharmaceuticals Group Co, Ltd., a clinical-stage pharmaceutical company, focusing on the in-house discovery and development of oncology therapies. The company's lead drug development programs include two clinical-stage allosteric Src homology region 2 domain-containing phosphatase-2 (SHP2) inhibitors comprising JAB-3312 and JAB-3068 for the treatment of esophageal cancer; JAB-8263, a small molecule inhibitor of BET family proteins regulating MYC transcription to treat various cancers; and JAB-21822, an oral small molecule targeting mutant KRAS G12C protein.